STOK stock

Analysts Viewpoint

A company insider recently sold 3,978 shares of Stoke Therapeutics Inc [STOK]. Should You Sale?

Anna Perez

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...

Insiders Updates

Stoke Therapeutics Inc [STOK] Insider Allan Jonathan sells 3,978 Shares – Company Insider Activity

Samantha Gray

Stoke Therapeutics Inc’s recent filing unveils that its GENERAL COUNSEL & CORP SEC Allan Jonathan unloaded Company’s shares for reported ...

Analysts Viewpoint

Insider Selling: Allan Jonathan, Stoke Therapeutics Inc [STOK] GENERAL COUNSEL & CORP SEC divested 3,978 shares

Samantha Gray

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...

Analysts Viewpoint

Stoke Therapeutics Inc [NASDAQ: STOK] Sees Increase in Stock Value

Samantha Gray

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Stoke Therapeutics ...

Knox Daily
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.